NCT07357675: A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.
- State
- Under way
- Phase
- Phase 3
- People
- 300 planned
- Started
- 29 Oct 2026
- Primary completion
- 1 Oct 2027
- Arms
- EA-230 90mg/kg/hour
- Results
- None posted
- 22 Jan 2026: Trial registered
- 29 Oct 2026: Trial started